bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Short Interest Update

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the target of a large decrease in short interest in the month of July. As of July 15th, there was short interest totaling 691 shares, a decrease of 39.1% from the June 30th total of 1,134 shares. Based on an average daily trading volume, of 614 shares, the short-interest ratio is currently 1.1 days.

bioAffinity Technologies Stock Down 2.9%

Shares of NASDAQ BIAFW traded down $0.00 during midday trading on Thursday, reaching $0.09. 110 shares of the stock were exchanged, compared to its average volume of 2,406. The company has a 50 day simple moving average of $0.14 and a 200 day simple moving average of $0.24. bioAffinity Technologies has a twelve month low of $0.05 and a twelve month high of $0.81.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.